Joseph A Kaufman
Examiner (ID: 10129)
Most Active Art Unit | 3754 |
Art Unit(s) | 3752, 3993, 3727, 3754, 3108, 3104 |
Total Applications | 1964 |
Issued Applications | 1543 |
Pending Applications | 181 |
Abandoned Applications | 196 |
Applications
Application number | Title of the application | Filing Date | Status |
---|---|---|---|
Array
(
[id] => 9503765
[patent_doc_number] => 08742081
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-06-03
[patent_title] => 'Fluorescent GFP variant displaying highly increased fluorescence intensity without a spectral shift'
[patent_app_type] => utility
[patent_app_number] => 12/671495
[patent_app_country] => US
[patent_app_date] => 2008-08-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 13
[patent_no_of_words] => 12681
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 236
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12671495
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/671495 | Fluorescent GFP variant displaying highly increased fluorescence intensity without a spectral shift | Jul 31, 2008 | Issued |
Array
(
[id] => 5574974
[patent_doc_number] => 20090142335
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-06-04
[patent_title] => 'Methods of diagnosis and treatment of metabolic disorders'
[patent_app_type] => utility
[patent_app_number] => 12/220714
[patent_app_country] => US
[patent_app_date] => 2008-07-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 14597
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0142/20090142335.pdf
[firstpage_image] =>[orig_patent_app_number] => 12220714
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/220714 | Methods of diagnosis and treatment of metabolic disorders | Jul 27, 2008 | Abandoned |
Array
(
[id] => 9086147
[patent_doc_number] => 08557573
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-10-15
[patent_title] => 'Vector particles for targeting CD34+ cells'
[patent_app_type] => utility
[patent_app_number] => 12/670479
[patent_app_country] => US
[patent_app_date] => 2008-07-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 9
[patent_no_of_words] => 7190
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 10
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12670479
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/670479 | Vector particles for targeting CD34+ cells | Jul 22, 2008 | Issued |
Array
(
[id] => 6395717
[patent_doc_number] => 20100304353
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-12-02
[patent_title] => 'METHODS OF IMPROVING A GENOMIC MARKER INDEX OF DAIRY ANIMALS AND PRODUCTS'
[patent_app_type] => utility
[patent_app_number] => 12/669046
[patent_app_country] => US
[patent_app_date] => 2008-07-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 13699
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0304/20100304353.pdf
[firstpage_image] =>[orig_patent_app_number] => 12669046
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/669046 | METHODS OF IMPROVING A GENOMIC MARKER INDEX OF DAIRY ANIMALS AND PRODUCTS | Jul 14, 2008 | Abandoned |
Array
(
[id] => 8470037
[patent_doc_number] => 08299215
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-10-30
[patent_title] => 'Methods and compositions for treating brain diseases'
[patent_app_type] => utility
[patent_app_number] => 12/172121
[patent_app_country] => US
[patent_app_date] => 2008-07-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 24
[patent_no_of_words] => 17101
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 63
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12172121
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/172121 | Methods and compositions for treating brain diseases | Jul 10, 2008 | Issued |
Array
(
[id] => 6551783
[patent_doc_number] => 20100233250
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-09-16
[patent_title] => 'VACCINE'
[patent_app_type] => utility
[patent_app_number] => 12/665090
[patent_app_country] => US
[patent_app_date] => 2008-06-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 13694
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12665090
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/665090 | VACCINE | Jun 19, 2008 | Abandoned |
Array
(
[id] => 4711116
[patent_doc_number] => 20080299642
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-12-04
[patent_title] => 'VECTORS WITH MODIFIED PROTEASE-DEPENDENT TROPISM'
[patent_app_type] => utility
[patent_app_number] => 12/140715
[patent_app_country] => US
[patent_app_date] => 2008-06-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 50
[patent_figures_cnt] => 50
[patent_no_of_words] => 45865
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0299/20080299642.pdf
[firstpage_image] =>[orig_patent_app_number] => 12140715
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/140715 | Vectors with modified protease-dependent tropism | Jun 16, 2008 | Issued |
Array
(
[id] => 6024932
[patent_doc_number] => 20110053258
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-03-03
[patent_title] => 'Novel promoter sequence and the application thereof'
[patent_app_type] => utility
[patent_app_number] => 12/155393
[patent_app_country] => US
[patent_app_date] => 2008-06-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 7368
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0053/20110053258.pdf
[firstpage_image] =>[orig_patent_app_number] => 12155393
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/155393 | Novel promoter sequence and the application thereof | Jun 2, 2008 | Abandoned |
Array
(
[id] => 5272126
[patent_doc_number] => 20090075902
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-03-19
[patent_title] => 'INHIBITING THE SIGNS OF AGING BY INHIBITING NF-KAPPA B ACTIVATION'
[patent_app_type] => utility
[patent_app_number] => 12/126634
[patent_app_country] => US
[patent_app_date] => 2008-05-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 24
[patent_figures_cnt] => 24
[patent_no_of_words] => 9545
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0075/20090075902.pdf
[firstpage_image] =>[orig_patent_app_number] => 12126634
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/126634 | INHIBITING THE SIGNS OF AGING BY INHIBITING NF-KAPPA B ACTIVATION | May 22, 2008 | Abandoned |
Array
(
[id] => 4739997
[patent_doc_number] => 20080233650
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-09-25
[patent_title] => 'Method for propagating adenoviral vectors encoding inhibitory gene products'
[patent_app_type] => utility
[patent_app_number] => 12/118008
[patent_app_country] => US
[patent_app_date] => 2008-05-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13938
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0233/20080233650.pdf
[firstpage_image] =>[orig_patent_app_number] => 12118008
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/118008 | Method for propagating adenoviral vectors encoding inhibitory gene products | May 8, 2008 | Abandoned |
Array
(
[id] => 5575477
[patent_doc_number] => 20090142839
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-06-04
[patent_title] => 'Inducing Premature Senescence to Stabilize Stem Cell Feeder Layer Cells'
[patent_app_type] => utility
[patent_app_number] => 12/115451
[patent_app_country] => US
[patent_app_date] => 2008-05-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 15556
[patent_no_of_claims] => 37
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0142/20090142839.pdf
[firstpage_image] =>[orig_patent_app_number] => 12115451
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/115451 | Inducing Premature Senescence to Stabilize Stem Cell Feeder Layer Cells | May 4, 2008 | Abandoned |
Array
(
[id] => 5452172
[patent_doc_number] => 20090068209
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-03-12
[patent_title] => 'Cytotoxic Lymphocyte'
[patent_app_type] => utility
[patent_app_number] => 12/113822
[patent_app_country] => US
[patent_app_date] => 2008-05-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 12441
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0068/20090068209.pdf
[firstpage_image] =>[orig_patent_app_number] => 12113822
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/113822 | Cytotoxic T lymphocyte | Apr 30, 2008 | Issued |
Array
(
[id] => 5290450
[patent_doc_number] => 20090023180
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-01-22
[patent_title] => 'Reduction of Shading in Microalgae'
[patent_app_type] => utility
[patent_app_number] => 12/099106
[patent_app_country] => US
[patent_app_date] => 2008-04-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 17796
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0023/20090023180.pdf
[firstpage_image] =>[orig_patent_app_number] => 12099106
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/099106 | Reduction of Shading in Microalgae | Apr 6, 2008 | Abandoned |
Array
(
[id] => 7811179
[patent_doc_number] => 08133709
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-03-13
[patent_title] => 'Target sequences for synthetic molecules'
[patent_app_type] => utility
[patent_app_number] => 12/062031
[patent_app_country] => US
[patent_app_date] => 2008-04-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 19
[patent_no_of_words] => 14352
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 86
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/08/133/08133709.pdf
[firstpage_image] =>[orig_patent_app_number] => 12062031
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/062031 | Target sequences for synthetic molecules | Apr 2, 2008 | Issued |
Array
(
[id] => 6561057
[patent_doc_number] => 20100272691
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-10-28
[patent_title] => 'Viruses'
[patent_app_type] => utility
[patent_app_number] => 12/670551
[patent_app_country] => US
[patent_app_date] => 2008-04-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 25
[patent_figures_cnt] => 25
[patent_no_of_words] => 33248
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0272/20100272691.pdf
[firstpage_image] =>[orig_patent_app_number] => 12670551
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/670551 | Viruses | Apr 1, 2008 | Issued |
Array
(
[id] => 168025
[patent_doc_number] => 07666672
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-02-23
[patent_title] => 'Cell lines'
[patent_app_type] => utility
[patent_app_number] => 12/020874
[patent_app_country] => US
[patent_app_date] => 2008-01-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 12228
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 10
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/666/07666672.pdf
[firstpage_image] =>[orig_patent_app_number] => 12020874
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/020874 | Cell lines | Jan 27, 2008 | Issued |
Array
(
[id] => 6454716
[patent_doc_number] => 20100189729
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-07-29
[patent_title] => 'RNA-CODED ANTIBODY'
[patent_app_type] => utility
[patent_app_number] => 12/522214
[patent_app_country] => US
[patent_app_date] => 2008-01-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 28
[patent_figures_cnt] => 28
[patent_no_of_words] => 33734
[patent_no_of_claims] => 37
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0189/20100189729.pdf
[firstpage_image] =>[orig_patent_app_number] => 12522214
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/522214 | RNA-coded antibody | Jan 7, 2008 | Issued |
Array
(
[id] => 5508581
[patent_doc_number] => 20090081788
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-03-26
[patent_title] => 'Nucleotide sequence encoding the enzyme I-SceI and the uses thereof'
[patent_app_type] => utility
[patent_app_number] => 12/000888
[patent_app_country] => US
[patent_app_date] => 2007-12-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 47
[patent_figures_cnt] => 47
[patent_no_of_words] => 22461
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0081/20090081788.pdf
[firstpage_image] =>[orig_patent_app_number] => 12000888
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/000888 | Nucleotide sequence encoding the enzyme I-SceI and the uses thereof | Dec 17, 2007 | Abandoned |
Array
(
[id] => 5265527
[patent_doc_number] => 20090118212
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-05-07
[patent_title] => 'METHODS FOR PRODUCING AND USING IN VIVO PSEUDOTYPED RETROVIRUSES'
[patent_app_type] => utility
[patent_app_number] => 11/943871
[patent_app_country] => US
[patent_app_date] => 2007-11-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 15649
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0118/20090118212.pdf
[firstpage_image] =>[orig_patent_app_number] => 11943871
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/943871 | METHODS FOR PRODUCING AND USING IN VIVO PSEUDOTYPED RETROVIRUSES | Nov 20, 2007 | Abandoned |
Array
(
[id] => 5380262
[patent_doc_number] => 20090192101
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-07-30
[patent_title] => 'CANCER-SPECIFIC PROMOTERS'
[patent_app_type] => utility
[patent_app_number] => 11/943057
[patent_app_country] => US
[patent_app_date] => 2007-11-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 24
[patent_figures_cnt] => 24
[patent_no_of_words] => 29544
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0192/20090192101.pdf
[firstpage_image] =>[orig_patent_app_number] => 11943057
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/943057 | CANCER-SPECIFIC PROMOTERS | Nov 19, 2007 | Abandoned |